Clinical Study
Efficacy of Clopidrogel on Reperfusion and High-Sensitivity C-Reactive Protein in Patients with Acute Myocardial Infarction
Table 1
Baseline characteristics.
| Characteristics | Group
1 | Group
2 | P value |
| Mean age (year) | 57 ± 7 | 56 ± 5 | .31 | Men (%) | 79.3 | 80.7 | .48 | Time for symptom to lytic (h) | 2.7 ± 2 | 2.6 ± 1 | .56 | Presentation | | | | Heart rate (beat/min) | 75 ± 14 | 74 ± 12 | .37 | Systolic blood pressure (mmHg) | 133 ± 14 | 135 ± 16 | .31 | Diastolic blood pressure (mmHg) | 73 ± 11 | 75±15 | .29 | History (%) | | | | Current smoker | 44.8 | 44.6 | .51 | Diabetes mellitus | 17.2 | 19.3 | .44 | Hypertension | 29.9 | 32.5 | .35 | Hyperlipidemia | 27.6 | 31.3 | .35 | High TIMI risk score (≥5) | 13.8 | 14.8 | .33 | Medication during hospitalization (%) | | | | β-blocker | 93 | 94 | .50 | Statins | 90 | 93 | .51 | ACE-I or ARB | 73 | 74 | .43 |
|
|